Andrew Huberman· PhD
So in the world of inflammation, nobody has a single thing that they all like. Not C reactive protein, not interlucan 6, not trimethylamine oxide. There's all kinds of things floating out there, but there isn't one that clinicians agree on and measure in the clinic. So Mark Davis had found a sort of cluster of 14 different things in a paper that they found looking within that population. and they said maybe people should be looking at the cytoine response score and then on clinical trials.gov of we said that's our primary outcome and we're going to look at all this other stuff and in the cell paper cytoine response score didn't change and since then Mark Davis has kind of abandoned this this score because it hasn't been reproduced in other populations